NGM Insider Trading Activity and SEC Form 4 Filings
NGM insider trading summary
No open-market insider purchases or sales of Ngm Biopharmaceuticals Inc (NGM) have been reported on SEC Form 4 in the past 12 months.
Latest NGM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 16, 2023 | Column Group L P | Insider | Buy | $4K (5,840 @ $0.62) |
| Nov 16, 2023 | Column Group Iii-A, LP | Insider | Buy | $4K (5,840 @ $0.62) |
| Nov 16, 2023 | TCG Opportunity III GP, LLC | Insider | Buy | $4K (5,840 @ $0.62) |
| Nov 16, 2023 | Peter Svennilson | Insider | Buy | $4K (5,840 @ $0.62) |
| Nov 16, 2023 | Ponoi Capital II, LP | Insider | Buy | $4K (5,840 @ $0.62) |
| Nov 16, 2023 | David V Goeddel | Insider | Buy | $907 (1,460 @ $0.62) |
| Nov 16, 2023 | Column Group L P | Insider | Buy | $4K (5,840 @ $0.62) |
| Nov 16, 2023 | David V Goeddel | Insider | Buy | $4K (5,840 @ $0.62) |
| Nov 16, 2023 | Column Group L P | Insider | Buy | $4K (5,840 @ $0.62) |
| Nov 16, 2023 | Tim Kutzkey | Insider | Buy | $4K (5,840 @ $0.62) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.